Skip to Content

Coloplast A/S Class B CLPBF

Morningstar Rating
$127.71 −5.75 (4.31%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CLPBF is trading at a 5% premium.
Price
$128.09
Fair Value
$583.98
Uncertainty
Medium
1-Star Price
$248.17
5-Star Price
$969.52
Economic Moat
Kqn
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CLPBF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$133.46
Day Range
$127.71132.50
52-Week Range
$99.78145.05
Bid/Ask
$0.01 / $30,133.35
Market Cap
$28.71 Bil
Volume/Avg
1,219 / 906

Key Statistics

Price/Earnings (Normalized)
39.85
Price/Sales
7.64
Dividend Yield (Trailing)
2.38%
Dividend Yield (Forward)
2.38%
Total Yield
2.38%

Company Profile

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Large Growth
Total Number of Employees
15,751

Competitors

Valuation

Metric
CLPBF
SNN
BSX
Price/Earnings (Normalized)
39.8515.9632.75
Price/Book Value
12.792.215.10
Price/Sales
7.642.086.90
Price/Cash Flow
31.6712.2830.01
Price/Earnings
CLPBF
SNN
BSX

Financial Strength

Metric
CLPBF
SNN
BSX
Quick Ratio
0.350.830.63
Current Ratio
0.532.191.32
Interest Coverage
9.202.818.41
Quick Ratio
CLPBF
SNN
BSX

Profitability

Metric
CLPBF
SNN
BSX
Return on Assets (Normalized)
12.14%6.86%8.92%
Return on Equity (Normalized)
47.39%12.92%16.33%
Return on Invested Capital (Normalized)
16.96%9.28%11.43%
Return on Assets
CLPBF
SNN
BSX
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncSsn$140.2 Bil
BDX
Becton Dickinson & CoYtmwpq$68.0 Bil
ALC
Alcon IncKcfkpm$42.4 Bil
CLPBY
Coloplast A/S ADRPgxs$29.9 Bil
WST
West Pharmaceutical Services IncVdm$26.3 Bil
RMD
ResMed IncQmtsrtd$25.7 Bil
BAX
Baxter International IncPdjyzy$20.8 Bil
COO
The Cooper Companies IncBskrbf$20.3 Bil
HOLX
Hologic IncJjyjzd$17.3 Bil
TFX
Teleflex IncCqjhl$10.5 Bil

Sponsor Center